A small portion of H. pylori-infected subjects develop peptic ulcers and gastric carcinoma, usually in late adulthood. 2 In well-designed studies, H. pylori was found to be associated with increased likelihood of iron deficiency anemia (IDA) 3, 4 ; furthermore, anti-H. pylori therapy substantially reduced the percentage of children affected with IDA. 5 In a community-based study among Arab children in Israel, we found significantly lower mean hemoglobin levels in children ages 6-9 years who were infected with H. pylori compared with their uninfected peers. 6 H. pylori was also associated with low ferritin levels. 6, 7 In a systematic review and meta-analysis, 8 we found higher prevalence of IDA in H. pylori-infected subjects than uninfected ones (pooled odds ratio = 2.8; 95% confidence interval = 1.9-4.2). 8 We recommend the investigation of H. pylori infection as a potential factor that might play a role in the occurrence of anemia in this population. 1 Trials on the impact of anti-H. pylori therapy on the burden of anemia and IDA could shed light on whether the association between H. pylori and these disorders is causal.
